EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Investigation of cardiorenal outcomes and incidence of genitourinary tract infection after combined SGLT2 inhibitor and ACEI/ARB use in patients with chronic kidney disease stages 3-5: A real-world retrospective cohort study in Taiwan

Yu-Hsuan Joni Shao, Wan-Ting Chen, Samuel Mon-Wei Yu, Liam Li-An Tsou, Yung-Ho Hsu, Mai-Szu Wu, Yung-Hsi Kao, Chu-Lin Chou, Po-Jen Hsiao

International Journal of Medical Sciences · 2024

DOI: 10.7150/ijms.96969 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift International Journal of Medical Sciences, 2024. Verfasst von Yu-Hsuan Joni Shao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Angiotensin Receptor Antagonists, Renal Insufficiency, Chronic, Angiotensin-Converting Enzyme Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sodium-Glucose Transporter 2 InhibitorsAngiotensin Receptor AntagonistsRenal Insufficiency, ChronicAngiotensin-Converting Enzyme InhibitorsHumansTaiwanMaleFemaleMiddle AgedRetrospective StudiesIncidenceAgedDiabetes Mellitus, Type 2

Stichwörter der Autor:innen

acute kidney diseaseacute kidney injuryangiotensin-converting enzyme inhibitor (ACEI)/angiotensin receptor blocker (AR…cardiorenal outcomechronic kidney diseaseend-stage renal diseasegenitourinary tract infectionsodium‒glucose cotransporter-2 (SGLT2) inhibitor

Substanzen

Sodium-Glucose Transporter 2 InhibitorsAngiotensin Receptor AntagonistsAngiotensin-Converting Enzyme Inhibitors

Autor:innen und Institutionen

  • Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
  • Clinical Big Data Research Center, Taipei Medical University Hospital, Taipei, Taiwan.
  • Health and Clinical Research Data Center, Office of Data Science, Taipei Medical University, Taipei, Taiwan.
  • Division of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA.
  • Biochemistry, Department of Chemistry, Hofstra University, Hempstead, New York, USA.
  • Taipei Medical University-Research Center of Urology and Kidney, Taipei Medical University, Taipei, Taiwan.

Zitieren

APA

Shao, Y. J., Chen, W. T., Yu, S. M., Tsou, L. L., Hsu, Y. H., Wu, M. S., Kao, Y. H., Chou, C. L., & Hsiao, P. J. (2024). Investigation of cardiorenal outcomes and incidence of genitourinary tract infection after combined SGLT2 inhibitor and ACEI/ARB use in patients with chronic kidney disease stages 3-5: A real-world retrospective cohort study in Taiwan. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.96969

Vancouver

Shao YJ, Chen WT, Yu SM, Tsou LL, Hsu YH, Wu MS, et al. Investigation of cardiorenal outcomes and incidence of genitourinary tract infection after combined SGLT2 inhibitor and ACEI/ARB use in patients with chronic kidney disease stages 3-5: A real-world retrospective cohort study in Taiwan. International Journal of Medical Sciences. 2024. doi:10.7150/ijms.96969

BibTeX
@article{Shao2024,
  author = {Shao, Yu-Hsuan Joni and Chen, Wan-Ting and Yu, Samuel Mon-Wei and Tsou, Liam Li-An and Hsu, Yung-Ho and Wu, Mai-Szu and Kao, Yung-Hsi and Chou, Chu-Lin and Hsiao, Po-Jen},
  title = {Investigation of cardiorenal outcomes and incidence of genitourinary tract infection after combined SGLT2 inhibitor and ACEI/ARB use in patients with chronic kidney disease stages 3-5: A real-world retrospective cohort study in Taiwan},
  journal = {International Journal of Medical Sciences},
  year = {2024},
  doi = {10.7150/ijms.96969}
}
Kostenlos starten →